Cell-Free Nucleic Acids: Clinical Trials

3 trials of Cell-Free Nucleic Acids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1
Phase 31Recruiting 1

Follow Cell-Free Nucleic Acids: new trials by email Literature Review of Cell-Free Nucleic Acids trials Research Report on Cell-Free Nucleic Acids

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Biospecimen Collection, cfDNA or ctDNA Measurement, Computed Tomography - Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2 / Phase 3RecruitingNational Cancer Institute (NCI)9922024-02-022026-10-29
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer
Neoadjuvant chemotherapy with PSOX regimen., Detect the imaging data and levels of CTC, ctDNA, cfDNA, CEA, CA19-9, CA72-4 in plasma., Detect the tumor related DNA in pathological tissues after operation. - Gastric Cancer, Gastro-oesophageal Junction Cancer
Phase 2UnknownAffiliated Hospital of Qinghai University402019-05-282020-01-22
Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Irinotecan, Ramucirumab, Blood for angiome profiling - Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma
Phase 2CompletedWashington University School of Medicine402017-11-012024-06-25

Conditions studied

Neoplastic Cells, Circulating (1)  ·  Stomach Neoplasms (1)

Sponsors

Affiliated Hospital of Qinghai University (1)  ·  National Cancer Institute (NCI) (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  Canada (1)  ·  China (1)

Top investigators

Kian-Huat Lim, M.D., Ph.D. (1)  ·  Matthew D Galsky (1)

NIH funding

U10CA180821 (1)